CBFA2T3 and prostate adenocarcinoma: A multivariate analysis of CBFA2T3 CN suggested that it may be a protective factor in PRAD, whereas the Kaplan–Meier survival analysis suggested it was not statistically significant in the prognosis of patients with PRAD (Figure 6I and Table 2).